Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, OH
SEC filing record 1 source field available
Fiscal year end
31 December
NAVIDEA BIOPHARMACEUTICALS, INC. has filed 1,465 SEC EDGAR filings since 07 Feb 1995

SEC filing history

Showing 501-525 of 949 matching filings.

Per page
25
Current page
21
4

PRIMARY DOCUMENT

Filing date
29 Feb 2016
Reporting date
25 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Feb 2016
Reporting date
25 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Feb 2016
Reporting date
25 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

8-K

Filing date
11 Feb 2016
Reporting date
08 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
13 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
11 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
11 Jan 2016
Reporting date
06 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Jan 2016
Reporting date
06 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
31 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Dec 2015
Reporting date
01 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

8-K

Filing date
06 Nov 2015
Reporting date
04 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Nov 2015
Reporting date
02 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Oct 2015
Reporting date
08 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Oct 2015
Reporting date
09 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-35076

8-K/A

Filing date
09 Oct 2015
Reporting date
11 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Oct 2015
Reporting date
01 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Sep 2015
Reporting date
01 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
26 Aug 2015
Reporting date
20 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
05 Aug 2015
Reporting date
30 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Aug 2015
Reporting date
03 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Aug 2015
Reporting date
31 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

CURRENT REPORT

Filing date
28 Jul 2015
Reporting date
23 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Jul 2015
Reporting date
26 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .